Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
52-week range
$133.73 – $176.60
80% from low
Sector
Asset Management
Exchange
ARCX
ETF
The State Street Health Care Select Sector SPDR ETF (XLV) is designed to reflect, before expenses, the price and yield performance of the Health Care Select Sector Index. This benchmark offers a clear representation of the healthcare industry within the S&P 500. The fund provides focused exposure to companies across diverse healthcare fields, such as pharmaceuticals, medical equipment and supplies, healthcare providers and services, biotechnology, life sciences tools and services, and health technology. It allows investors to make targeted strategic or tactical allocations that are more precise than those offered by traditional style-based investment vehicles.
www.ssga.com/us/en/institutional/etfs/state-street-health-care-select-sector-spdr-etf-xlvNo one on the platform currently holds XLV.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 91,700 | $13.4M |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-06-22 | $0.6563 | 2026-06-24 |
| 2026-03-23 | $0.5947 | 2026-03-25 |
| 2025-12-22 | $0.6568 | 2025-12-24 |
| 2025-09-22 | $0.6249 | 2025-09-24 |
| 2025-06-23 | $0.6304 | 2025-06-25 |
| 2025-03-24 | $0.5645 | 2025-03-26 |
| 2024-12-23 | $0.6217 | 2024-12-26 |
| 2024-09-23 | $0.5772 | 2024-09-25 |
| 2024-06-24 | $0.5725 | 2024-06-26 |
| 2024-03-18 | $0.5229 | 2024-03-21 |
No one on the platform has traded XLV yet.
| 2023-12-18 | $0.5977 | 2023-12-21 |
| 2023-09-18 | $0.5395 | 2023-09-21 |
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
The State Street Health Care Select Sector SPDR ETF (XLV) is designed to reflect, before expenses, the price and yield performance of the Health Care Select Sector Index. This benchmark offers a clear representation of the healthcare industry within the S&P 500. The fund provides focused exposure to companies across diverse healthcare fields, such as pharmaceuticals, medical equipment and supplies, healthcare providers and services, biotechnology, life sciences tools and services, and health technology. It allows investors to make targeted strategic or tactical allocations that are more precise than those offered by traditional style-based investment vehicles.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| XLVState Street Health Care Select Sector SPDR ETF | $167.66 | -0.05% | $43.1B | — |
| DFACDimensional - US Core Equity 2 ETF | $44.75 | -0.44% | $47.7B | — |
| DGROiShares Core Dividend Growth ETF | $77.59 | -0.78% | $40.9B | — |
| DIAState Street SPDR Dow Jones Industrial Average ETF Trust | $521.23 | -0.62% | $43.8B | — |
| SCHBSchwab U.S. Broad Market ETF |
| $29.19 |
| -0.48% |
| $43.8B |
| — |
| SMHVanEck Semiconductor ETF | $542.11 | +0.11% | $68.3B | — |
| VBKVanguard Morningstar Small-Cap Growth ETF | $335.90 | -0.77% | $46.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
🎯 $XLV Blue Box worked again. We identified 171.13–168.15 as the Blue Box support area, where buyers could step in. Price reached the zone and delivered the expected reaction higher. WHAT HAPPENS NEXT: As long as XLV stays above 168.15, the bullish sequence remains intact. Short-term pullbacks in 3, 7, or 11 swings should continue to find buyers before the next leg higher. #XLV #Healthcare #ETF #ElliottWave #Trading #BlueBox
View on StockTwits ↗$LLY never got going. Just a slow, stubborn grind lower. Sold the morning pop into the 63 EMA for a moderate loss. $STUDY $XLV
View on StockTwits ↗$OTLK do you think the #fed might partially help contribute to a drop for #biotech? $XLV
View on StockTwits ↗What might be closest to your next entry point for $NVS ? $XLV $PILL $JNJ
View on StockTwits ↗$EW $IHI $XLV $SPY Edwards Lifescienes (EW) - Weekly Chart
View on StockTwits ↗$NSYS Healthcare sector $XLV down in the dumps, but should rebound soon.
View on StockTwits ↗$MRNA shorting this insanely overvalued, overhyped turd all day… $BACK to $100. 👎 $XBI $XLV $IWM
View on StockTwits ↗Relative strength in tech the past week while healthcare was hit the hardest $XLV $XLK $XLE
View on StockTwits ↗$XLV — The Blue Box Did Its Job. Now the Focus Shifts to New Highs We identified the 171.13–168.15 Blue Box as the key buying zone while XLV was completing a 3-wave zigzag correction. Price reached the zone, buyers stepped in as expected, and the reaction was strong enough to make the setup risk-free with stops moved to breakeven. 📈 WHAT HAPPENS NEXT: As long as the latest low holds, the preferred path is for XLV to continue higher and break to new highs. If that low fails, we would look for the deeper correction to create the next buying opportunity. 👉 https://elliottwave-forecast.com/etfs/xlv-elliott-wave-another-trading-setup-presented-to-members/ #XLV #ElliottWave #BlueBox #ETFs #Trading #TechnicalAnalysis
View on StockTwits ↗$SPY >> look at $XLE $XLU $XLV The energy rally is losing steam 📉, utilities have been cooling down, and health care is actually hitting the 50 SMA which is the bounce zone The defensive sectors run when tech $QQQ us under pressure If the defensive drops tech likely pops Looks like this is the setup to possibly bounce
View on StockTwits ↗$IRTC Buyer…this is a $175-200 stock. $IWM $IHI $XLV
View on StockTwits ↗Two segments of the market that have flourished through their period of seasonal strength may be ripe for profit-taking amidst a degradation in macro fundamentals. https://equityclock.com/2026/09/09/stock-market-outlook-for-september-10-2026/ $IGV $XLV $SPY
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.